Emera (EMRAF)
OTC: EMRAF
· Real-Time Price · USD
45.13
0.18 (0.40%)
At close: May 27, 2025, 3:50 PM
Emera Income Statement
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.87B | 7.05B | 7.13B | 7.07B | 6.86B | 7.43B | 7.95B | 8.04B | 8.01B | 7.59B | 7.1B | 6.41B | 6.17B | 5.76B | 5.43B | 5.45B | 5.48B |
Cost of Revenue | 4.71B | 4.59B | 4.84B | 5.21B | 4.83B | 4.82B | 4.66B | 4.49B | 4.63B | 4.57B | 4.39B | 4.12B | 3.85B | 3.6B | 3.42B | 3.22B | 3.1B |
Gross Profit | 3.16B | 2.19B | 2.02B | 1.58B | 1.76B | 2.62B | 3.29B | 3.56B | 3.38B | 3.02B | 2.71B | 2.29B | 2.31B | 2.16B | 2.02B | 2.23B | 2.38B |
Operating Income | 1.57B | 1.08B | 1.2B | 1.26B | 1.19B | 1.65B | 2.01B | 2.08B | 2B | 1.69B | 1.48B | 1.09B | 1.07B | 930M | 778M | 1B | 1.16B |
Interest Income | 23M | 26M | 64M | 55M | 51M | 49M | 212M | 396M | 391M | 390M | 184M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 876M | 409M | 793M | 816M | 641M | 1.13B | 1.42B | 1.57B | 1.46B | 1.19B | 964M | 630M | 687M | 555M | 473M | 684M | 825M |
Net Income | 943M | 567M | 749M | 828M | 725M | 1.08B | 1.22B | 1.3B | 1.21B | 1.01B | 849M | 608M | 654M | 560M | 506M | 646M | 733M |
Selling & General & Admin | -9M | -9M | 18M | 18M | 20M | 20M | 14M | 16M | 25M | 27M | 19M | 21M | 24M | 26M | 21M | 21M | 19M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 1.85B | 1.8B | 1.3B | 555M | 222M | 191M | 644M | 1.1B | 1.36B | 1.32B | 982M | 651M | 355M | 45M | 49M | 53M | 45M |
Operating Expenses | 1.86B | 1.81B | 1.52B | 2.36B | 2.33B | 2.3B | 2.54B | 1.41B | 1.36B | 1.32B | 1.28B | 1.26B | 1.24B | 1.23B | 1.21B | 1.2B | 1.19B |
Interest Expense | 987M | 981M | 979M | 968M | 953M | 931M | 896M | 845M | 780M | 709M | 654M | 620M | 610M | 611M | 619M | 632M | 652M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.29B | 6.12B | 6.08B | 5.96B | 5.82B | 5.78B | 5.87B | 5.89B | 5.99B | 5.89B | 5.67B | 5.38B | 5.1B | 4.83B | 4.63B | 4.42B | 4.29B |
Income Tax Expense | -68M | -159M | 91M | 36M | -36M | 98M | 201M | 267M | 252M | 185M | 116M | 22M | 33M | -6M | -34M | 37M | 91M |
Shares Outstanding (Basic) | 297M | 290M | 290M | 287.3M | 285.1M | 277.7M | 273.6M | 272.3M | 270.7M | 268.33M | 266.6M | 264.4M | 261.8M | 261.8M | 258.5M | 255.8M | 253.5M |
Shares Outstanding (Diluted) | 297.3M | 290.1M | 290.1M | 287.4M | 285.2M | 277.88M | 273.8M | 272.6M | 271M | 268.33M | 267M | 264.4M | 262.3M | 262.3M | 258.5M | 255.8M | 253.8M |
EPS (Basic) | 3.77 | 1.72 | 2.23 | 2.59 | 2.30 | 3.64 | 4.40 | 4.72 | 4.36 | 3.73 | 3.22 | 2.31 | 2.49 | 2.13 | 1.96 | 2.52 | 2.78 |
EPS (Diluted) | 3.77 | 1.72 | 2.23 | 2.59 | 2.30 | 3.64 | 4.40 | 4.72 | 4.36 | 3.73 | 3.22 | 2.31 | 2.49 | 2.13 | 1.96 | 2.52 | 2.77 |
EBITDA | 2.86B | 2.29B | 2.64B | 2.62B | 2.53B | 2.96B | 3.17B | 3.24B | 3.09B | 2.75B | 2.44B | 1.99B | 2B | 1.85B | 1.71B | 1.93B | 2.09B |
EBIT | 1.86B | 1.39B | 1.77B | 1.78B | 1.59B | 2.06B | 2.32B | 2.38B | 2.21B | 1.87B | 1.59B | 1.25B | 1.3B | 1.17B | 1.06B | 1.28B | 1.44B |
Depreciation & Amortization | 1.2B | 1.17B | 1.14B | 1.12B | 1.09B | 1.06B | 1.05B | 1.02B | 987M | 961M | 938M | 923M | 917M | 915M | 903M | 896M | 894M |